Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atheromatous embolization.

Yin Ping Liew1, John R Bartholomew

  • 1Department of Cardiovascular Medicine, Section of Vascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.

Vascular Medicine (London, England)
|February 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring uric acid as a biomarker in lipedema and lymphedema: A metabolomics study with prospective validation.

Obesity medicine·2026
Same author

Lymphedema vs lipedema: Similar but different.

Cleveland Clinic journal of medicine·2024
Same author

Venous thromboembolic outcomes in patients with lymphedema and lipedema: An analysis from the National Inpatient Sample.

Vascular medicine (London, England)·2024
Same author

Images in Vascular Medicine: Mondor's disease due to high-output arteriovenous fistula.

Vascular medicine (London, England)·2024
Same author

Images in Vascular Medicine: Nonuremic calciphylaxis secondary to occult malignancy.

Vascular medicine (London, England)·2023
Same author

Remembering Jess R Young, MD, MSVM (1928-2021): SVM Founding Member and First President.

Vascular medicine (London, England)·2022

Atheromatous embolization, a complication of advanced atherosclerosis, often goes unrecognized but can cause severe organ damage. Early diagnosis and aggressive management are crucial for better patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Nephrology

Background:

  • Atheromatous embolization is a multisystem disease linked to advanced atherosclerosis.
  • It frequently complicates procedures like angiography, endovascular interventions, and cardiovascular surgery.
  • This condition can present subtly or with severe consequences, including myocardial infarction, stroke, and acute renal failure.

Purpose of the Study:

  • To highlight the under-recognized nature of atheromatous embolization.
  • To emphasize the importance of high clinical suspicion for timely diagnosis.
  • To discuss management strategies for improving clinical outcomes and preventing end-organ damage.

Main Methods:

  • Clinical review of atheromatous embolization.

Related Experiment Videos

  • Analysis of presentation, diagnosis, and management strategies.
  • Discussion of risk factors and expected increase in prevalence.

    • Main Results:

    • Atheromatous embolization is often underdiagnosed due to its subtle presentation and mimicry of other diseases.
    • High clinical suspicion is essential for diagnosis.
    • Significant morbidity and mortality are associated with this condition.

    Conclusions:

    • Early recognition and aggressive management of atheromatous embolization are vital to prevent end-organ damage.
    • Management includes risk factor modification, avoiding predisposing factors, supportive care, and source removal.
    • The prevalence of atheromatous embolization is projected to rise with aging populations and increasing rates of diabetes and obesity.